Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-13 | Dr. Zaks received his M.D. and Ph.D. from Ben Gurion University in Israel, conducted post-doctoral research at the U.S. National Institutes of Health and completed clinical training in internal medicine at Temple University Hospital, followed by a fellowship in medical oncology at the University of Pennsylvania. |
| 2023-04-19 | Dr. Zaks is a partner at OrbiMed Advisors LLC and former Chief Medical Officer of Moderna, Inc., with an M.D. and Ph.D. from Ben Gurion University. |
| 2024-04-16 | Dr. Zaks joined the Board of Directors in 2021... Dr. Zaks received his M.D. and Ph.D. from Ben Gurion University in Israel, conducted post-doctoral research at the U.S. National Institutes of Health and completed clinical training in internal medicine at Temple University Hospital, followed by a fellowship in medical oncology at the University of Pennsylvania. |
Data sourced from SEC filings. Last updated: 2025-07-01